Results 271 to 280 of about 2,864,300 (339)

Ascites characteristics in acute pancreatitis: A prognostic indicator of organ failure and mortality. [PDF]

open access: yesWorld J Gastroenterol
Rao JW   +12 more
europepmc   +1 more source

Experimental Acute Pancreatitis in Mice

open access: bronze, 1979
Tadao Manabe, Michael L. Steer
openalex   +1 more source

A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies, a multicenter retrospective cohort study

open access: yesJournal of Diabetes Investigation, EarlyView.
This study developed a clinical model using a gradient boosting decision tree (GBDT) to predict blood glucose reduction (ΔGlu) after continuous intravenous insulin therapy in hyperglycemic emergencies. A multicenter retrospective cohort analysis identified key predictive factors, including initial blood glucose, bicarbonate concentration, insulin flow ...
Yuichiro Iwamoto   +18 more
wiley   +1 more source

Tetrahedron DNA Nanostructures as microRNA Inhibitors to Alleviate Acute Pancreatitis. [PDF]

open access: yesJACS Au
Li Y   +16 more
europepmc   +1 more source

Immune checkpoint inhibitor‐induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy—A multicentre analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Background, key points, current state of management in dermato‐oncology centres and algorithm for standardized monitoring and management of ICIPI; *routine radiographic imaging according to respective guidelines; **3 months after routine radiographic staging (6‐monthly); ***if not recently performed as part of the routine staging.
M. Brandlmaier   +14 more
wiley   +1 more source

S100A11 Promotes Acute Pancreatitis by Upregulating Acinar Cell Ferroptosis. [PDF]

open access: yesMediators Inflamm
Zhu H   +12 more
europepmc   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy